Detalles MARC
| 000 -LEADER |
|---|
| fixed length control field |
05626nam a2200349 a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MX-TeUDD |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20211004163320.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
030709s2002 pauad gr 001 0 eng c |
| 020 ## - Número Internacional Normalizado para Libros (ISBN) |
|---|
| Número Internacional Normalizado para Libros (ISBN) |
0781720060 |
| 020 ## - Número Internacional Normalizado para Libros (ISBN) |
|---|
| Número Internacional Normalizado para Libros (ISBN) |
9780781720069 |
| 040 ## - Agencia de catalogación original |
|---|
| Agencia que catalogó originalmente la obra |
MX-TeUDD |
| Idioma en que se cataloga |
spa |
| Agencia que transcribió la catalogación |
MX-TeUDD |
| 041 ## - Código de Idioma |
|---|
| Código de Idioma para texto o pista de sonido o título separado |
eng |
| 050 04 - Clasificación de la Biblioteca del Congreso |
|---|
| Número de Clasificación |
RC280.P7 |
| Número Cutter (y año) |
R6 2002 |
| 245 00 - Mención de título |
|---|
| Título |
Prostate cancer : |
| Resto del título |
principles and practice / |
| Mención de responsabilidad, etc. |
edición, Philip W. Kantoff, Peter R. Carroll, Anthony V. D'Amico. |
| 246 2# - Variante de título |
|---|
| Título propiamente dicho/Título corto |
Principles and practice. |
| 260 ## - Pie de imprenta |
|---|
| Lugar de publicación o distribución, etc. |
Philadelphia, U.S.A. : |
| Nombre de la editorial, distribuidor, etc. |
Lippincott Williams & Wilkins, |
| Fecha de publicación, distribución, etc. |
2002 |
| 300 ## - Descripción física |
|---|
| Extensión de la obra (paginación, volúmenes o tomos) |
xv, 748 p. : |
| Otros detalles físicos (ilustraciones , tablas, etc.) |
il., gráf. ; |
| Dimensiones (en centímetros) |
29 cm. |
| 500 ## - Nota general |
|---|
| Nota General |
Covers various aspects of diagnosis and screening and forms of accepted treatments of the prostate, with emphasis on the retention of sexual and physiological function. This work includes coverage of advanced androgen-sensitive and androgen-refractory disease. It also discusses the impact of advances in genetic understanding of prostate cancer. |
| 504 ## - Nota de bibliografía, etc. |
|---|
| Nota de Bibliografía, etc. |
Incluye referencias bibliográficas. |
| 505 2# - Nota de contenido con formato |
|---|
| Nota de contenido formateada |
I. Biology.-- <br/>1 Gross and Applied Anatomy of the Prostate.-- <br/>2 Cellular and Molecular Biology of Prostatic Development.-- <br/>3 Nuclear Receptors in Normal Prostatic Growth and Disease.-- <br/>4 Somatic Genetics of Prostate Cancer: Oncogenes and Tumor Suppressors.-- <br/>5 Antisurvival Therapy for Metastatic Prostate Cancer.-- <br/>6 Evolution of Hormone-Refractory Prostate Cancer.-- <br/>7 Prostate Cancer Prevention.-- <br/><br/>II. Epidemiology.-- <br/>8 Nutritional and Environmental Epidemiology of Prostate Cancer.-- <br/>9 Genetic Epidemiology of Prostate Cancer.-- <br/>10 Familial Prostate Cancer.-- <br/>11 Race and Risk.-- <br/>12 Conservative Management of Localized Prostate Cancer.-- <br/>13 Clinical Epidemiology: Incidence Rates, Databases, Age, and Co-Morbidity.-- <br/><br/>III. Diagnosis and Staging.-- <br/>14 Screening for Prostate Cancer: Prostate-Specific Antigen, Digital Rectal Examination, and Free, Density, and Age-specific Derivatives<br/>15 Serum Tumor Markers in Prostate Cancer.-- <br/>16 Systematic Biopsy of the Prostate: Applications for Detection, Staging, and Risk Assessment.-- <br/>17 Pathology.--<br/>18 Combined-Modality Staging in Predicting Prostate-Specific Antigen Outcome after Definitive Local Therapy for Men with Clinically Localized Prostate Cancer.-- <br/>19 Imaging and Staging of Prostate Cancer.-- <br/>20 Molecular Staging of Prostate Cancer.-- <br/><br/>IV. Early Prostate Cancer-Single Modality Treatment.-- <br/>21 Surgical Therapy of Clinically Localized Prostate Cancer Rationale. Patient Selection, and Outcomes.-- <br/>22 External Beam Radiation Therapy: Conventional and Conformal.-- <br/>23 Brachytherapy as Monotherapy.-- <br/>24 New Methods of Focal Ablation of the Prostate.-- <br/>25 Quality Of Life in Prostate Cancer.-- <br/>26A Management Considerations of Urinary Incontinence and Erectile Dysfunction after Local Therapy for Prostate Cancer.-- <br/>26B Management of Radiation Injury to the Bowel.-- <br/>27 Management Considerations for the Patient With Low-Risk Disease.-- <br/><br/>V. Early Prostate Cancer-multimodality Treatment.-- <br/>28 Combined External Beam Radiation Therapy or Brachytherapy and Hormones.-- <br/>29 Combination External Beam Radiation Therapy and Brachytherapy for Clinically Localized Prostate Cancer.-- <br/>30 Proton Bearn Therapy in Prostate Cancer.-- <br/>31 Neoadjuvant Androgen Deprivation Before Radical Prostatectomy for Prostate Adenocarcinoma.-- <br/>32 Management of High-Risk Prostate Cancer.-- <br/>33 Adjuvant External Beam Radiation Therapy Postprostatectomy.-- <br/>34 Adjuvant Hormonal Therapy for Prostate Cancer.-- <br/><br/>VI. Advanced Hormone Sensitive Disease.-- <br/>35 Defining Treatment Failure after Local Treatment and Restaging.-- <br/>36 Local Therapy for Recurrent Prostate Cancer.-- <br/>37 Salvage Radiation after Radical Prostatectory.-- <br/>38 Systemic Management Of The Patient With Prostate Cancer And A Rising Prostate-specific Antigen After Definitive Treatment.-- <br/>39 Prognostic Factors for Response and Survival With Hormone Therapy.-- <br/>40 Androgen Ablation for Prostate Cancer Mechanisms and Modalities.-- <br/>41 Combined Androgen Blockade for the Treatment of Metastatic Caricer of the Prostate.-- <br/>42 Alternative Hormone Approaches Intermittent. Penipheral, Triple.-- <br/>43 Second Line Hormone Therapy.-- <br/><br/>VII. Hormone-Refractory Disease.-- <br/>44 Pain and Symptom Management.-- <br/>45 Management of Bone Metastases. External Beam Radiation Therapy. Radiopharmaceuticals, and Bisphosphonates.-- <br/>46 Hematologic Complications of Prostate Cancer.-- <br/>47 Neurologic Complications of Prostate Cancer.-- <br/>48 Orthopedic Considerations: Implications and Management of Metastatic Prostate Cancer.-- <br/>49 Psychosocial Considerations in Prostate Cancer.-- <br/>VIII. Hormone Refractory Disease-Current Standards and Future Directions.-- <br/>50 Clinical Trial Design for Prostate Cancer.-- <br/>51 Chemotherapy for Androgen-Independent Prostate Cancer.-- <br/>52 Novel Tumor-Directed Therapeutic Strategies for Hormone-Refractory Prostate Cancer.-- <br/>53 Tumor Environment as the Target: Novel Therapeutics, Including Antiangiogenesis and Antimetastatics.-- <br/>54 Cancer Vaccines and Genetic Immunotherapy for Prostate Cancer.-- <br/>55 Complementary and Alternative Medicine. |
| 546 ## - Nota de idioma |
|---|
| Nota de idioma |
Texto en inglés. |
| 650 #4 - Asiento secundario de materia - Término de materia |
|---|
| Término temático o nombre geográfico como elemento de entrada |
Tumores prostásticos |
| 650 #4 - Asiento secundario de materia - Término de materia |
|---|
| Término temático o nombre geográfico como elemento de entrada |
Próstata - |
| Subdivisión general |
Cáncer. |
| 650 #4 - Asiento secundario de materia - Término de materia |
|---|
| Término temático o nombre geográfico como elemento de entrada |
Prostate - |
| Subdivisión general |
Cáncer. |
| 650 #0 - Asiento secundario de materia - Término de materia |
|---|
| Término temático o nombre geográfico como elemento de entrada |
Prostate - |
| Subdivisión general |
Cancer. |
| 700 1# - Entrada Secundaria - Nombre Personal |
|---|
| Nombre Personal |
D'Amico, Anthony V., |
| Término de relación |
ed. |
| 700 1# - Entrada Secundaria - Nombre Personal |
|---|
| Nombre Personal |
Kantoff, Philip, |
| Término de relación |
ed. |
| 700 1# - Entrada Secundaria - Nombre Personal |
|---|
| Nombre Personal |
Carroll, Peter R., |
| Término de relación |
ed. |
| 905 ## - LOCAL DATA (905) |
|---|
| Código de material |
Acervo |
| 906 ## - LOCAL DATA (906) |
|---|
| Catalogador |
Rosy |
| Fecha |
20030709 |
| 942 ## - Elementos de entrada secundarios (KOHA) |
|---|
| Tipo de Item de Koha |
01-Préstamo Interno (Libros) |
| Source of classification or shelving scheme |
Library of Congress Classification |
| 650 #4 - Asiento secundario de materia - Término de materia |
|---|
| -- |
19897 |
| 650 #4 - Asiento secundario de materia - Término de materia |
|---|
| -- |
20908 |
| 700 1# - Entrada Secundaria - Nombre Personal |
|---|
| -- |
19900 |
| 700 1# - Entrada Secundaria - Nombre Personal |
|---|
| -- |
19901 |
| 700 1# - Entrada Secundaria - Nombre Personal |
|---|
| -- |
19902 |